BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND hCG AND Clinical Outcome
21 results:

  • 1. miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular germ cell Cancers Before, During and After Chemotherapy.
    Rosas Plaza X; van Agthoven T; Meijer C; van Vugt MATM; de Jong S; Gietema JA; Looijenga LHJ
    Cells; 2019 Oct; 8(10):. PubMed ID: 31597402
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Management of mature pineal region teratomas in pediatric age group.
    Tanrıkulu B; Özek MM
    Childs Nerv Syst; 2020 Jan; 36(1):153-163. PubMed ID: 31144023
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [A case of urothelial carcinoma with trophoblastic differentiation and review of the literature].
    Cazorla A; Sibony M; Pedron P; Munz-Beaugrand C
    Ann Pathol; 2016 Oct; 36(5):347-350. PubMed ID: 27639773
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A retrospective analysis of patients treated for gestational trophoblastic diseases: a 4-year experience of a tertiary hospital.
    Cekmez Y; Arslan O; Turkmen SB; Guler AH; Kiran G
    Eur J Gynaecol Oncol; 2016; 37(6):817-819. PubMed ID: 29943928
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The impact of ultrasonographic lesion size and initial human chorionic gonadotropin values on treatment success in cases with complete hydatidiform mole.
    Seckin KD; Baser E; Yeral I; Togrul C; Ozdal B; Gungor T
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3381-4. PubMed ID: 24379071
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic significance of soluble fas and soluble fas ligand in serum of patients with complete hydatidiform moles.
    Soni S; Rath G; Deval R; Salhan S; Mishra AK; Saxena S
    Am J Reprod Immunol; 2011 Sep; 66(3):230-6. PubMed ID: 21385271
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Persistence and malignant sequelae of gestational trophoblastic disease: clinical presentation, diagnosis, treatment and outcome.
    Khoo SK; Sidhu M; Baartz D; Yip WL; Tripcony L
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):81-6. PubMed ID: 20219003
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease.
    Pezeshki M; Hancock BW; Silcocks P; Everard JE; Coleman J; Gillespie AM; Tidy J; Coleman RE
    Gynecol Oncol; 2004 Dec; 95(3):423-9. PubMed ID: 15581942
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Significance of chest computed tomography findings in the evaluation and treatment of persistent gestational trophoblastic neoplasia.
    Gamer EI; Garrett A; Goldstein DP; Berkowitz RS
    J Reprod Med; 2004 Jun; 49(6):411-4. PubMed ID: 15283046
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours.
    Zurita AJ; Diestra JE; Condom E; García Del Muro X; Scheffer GL; Scheper RJ; Pérez J; Germà-Lluch JR; Izquierdo MA
    Br J Cancer; 2003 Mar; 88(6):879-86. PubMed ID: 12644825
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Malignant placental site trophoblastic tumor: a cytogenetic study using comparative genomic hybridization and chromosome in situ hybridization.
    Xue WC; Guan XY; Ngan HY; Shen DH; Khoo US; Cheung AN
    Cancer; 2002 Apr; 94(8):2288-94. PubMed ID: 12001129
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Telomerase activity in complete hydatidiform mole.
    Sukcharoen N; Mutirangura A; Limpongsanurak S
    J Reprod Med; 1999 May; 44(5):465-70. PubMed ID: 10360262
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. clinical outcome of micrometastasis in the lung in stage IA persistent gestational trophoblastic disease.
    Ngan HY; Chan FL; Au VW; Cheng DK; Ng TY; Wong LC
    Gynecol Oncol; 1998 Aug; 70(2):192-4. PubMed ID: 9740689
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Metastasizing placental site trophoblastic tumor: immunohistochemical and DNA analysis. 2 case reports and a review of the literature.
    Remadi S; Lifschitz-Mercer B; Ben-Hur H; Dgani R; Czernobilsky B
    Arch Gynecol Obstet; 1997; 259(2):97-103. PubMed ID: 9059751
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [The study of DNA fingerprint of hydatidiform moles and the clinical outcome].
    Zhang X; Zhang L; Zhou X
    Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):203-5. PubMed ID: 8758772
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Detection of abnormal intrauterine vascularization by color Doppler imaging: a possible additional aid for the follow up of patients with gestational trophoblastic tumors.
    Zanetta G; Lissoni A; Colombo M; Marzola M; Cappellini A; Mangioni C
    Ultrasound Obstet Gynecol; 1996 Jan; 7(1):32-7. PubMed ID: 8932629
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Malignant trophoblastic tumors: immunohistochemical and flow cytometric comparison of choriocarcinoma and placental site trophoblastic tumors.
    Fukunaga M; Ushigome S
    Hum Pathol; 1993 Oct; 24(10):1098-106. PubMed ID: 7691711
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
    Gerl A; Clemm C; Lamerz R; Mann K; Wilmanns W
    Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A controlled trial of bestatin in hydatidiform mole.
    Ho PC; Wong LC; Lawton JW; Ma HK
    Cancer Immunol Immunother; 1990; 31(3):187-90. PubMed ID: 2186854
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [clinical outcome of adult testicular tumor. II. Study on patients with positive human chorionic gonadotropin].
    Sakuramoto T; Kihara K; Kawai T
    Hinyokika Kiyo; 1984 May; 30(5):639-49. PubMed ID: 6089533
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.